2012 focused update of the ESC Guidelines for the management of atrial fibrillation

The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation

(2013) Daniel E. Singer   ANNALS OF INTERNAL MEDICINE

Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable

(2013) Stuart J. Connolly   ANNALS OF INTERNAL MEDICINE

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial

(2013) Jonas Oldgren   ANNALS OF INTERNAL MEDICINE

Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation

(2013) James V. Freeman et al.   ANNALS OF INTERNAL MEDICINE

Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study

(2012) Jonas Bjerring Olesen et al.   AMERICAN JOURNAL OF MEDICINE

Dabigatran Association With Higher Risk of Acute Coronary Events

(2012) Ken Uchino   ARCHIVES OF INTERNAL MEDICINE

Effect of Aspirin on Vascular and Nonvascular Outcomes

(2012) Sreenivasa Rao Kondapally Seshasai   ARCHIVES OF INTERNAL MEDICINE

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

(2012) Allan C. Skanes et al.   CANADIAN JOURNAL OF CARDIOLOGY

Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation

(2012) Lori D. Bash et al.   CARDIOVASCULAR DRUGS AND THERAPY

Safety and Outcomes following Thrombolytic Treatment in Stroke Patients Who Had Received Prior Treatment with Anticoagulants

(2012) María-Consuelo Matute et al.   CEREBROVASCULAR DISEASES

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

(2012) Stefan H. Hohnloser et al.   CIRCULATION

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

(2012) Deirdre A. Lane et al.   CIRCULATION

Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

(2012) Pilar Gallego et al.   Circulation-Arrhythmia and Electrophysiology

Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation

(2012) Tatjana S. Potpara et al.   Circulation-Arrhythmia and Electrophysiology

Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

(2012) Juan M. Ruiz-Nodar et al.   Circulation-Cardiovascular Interventions

ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

(2012) E. Arbelo et al.   EUROPACE

Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial

(2012) A. J. Camm et al.   EUROPACE

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project

(2012) Amitava Banerjee et al.   EUROPEAN JOURNAL OF HEART FAILURE

Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation

(2012) Cynthia A. Jackevicius   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

(2012) Raffaele De Caterina et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

(2012) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Hybrid Thoracoscopic Surgical and Transvenous Catheter Ablation of Atrial Fibrillation

(2012) Laurent Pison et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation

(2012) Rashmee U. Shah et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2012) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation

(2012) Stavros Apostolakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

(2012) Paulus Kirchhof et al.   LANCET

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation

(2012) Jens Cosedis Nielsen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

(2012) Raphael Marlu et al.   THROMBOSIS AND HAEMOSTASIS

Oral anticoagulation use by patients with atrial fibrillation in Germany

(2012) Antje Groth et al.   THROMBOSIS AND HAEMOSTASIS

Impact of dabigatran on a large panel of routine or specific coagulation assays

(2012) Séverine Robert et al.   THROMBOSIS AND HAEMOSTASIS

The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation

(2012) Heyder Omran et al.   THROMBOSIS AND HAEMOSTASIS

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

(2012) Christian Torp-Pedersen et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice

(2012) Gregory Y. H. Lip et al.   THROMBOSIS AND HAEMOSTASIS

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

(2012) L. Friberg et al.   BMJ-British Medical Journal

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis

(2011) Pierre Sié et al.   Archives of Cardiovascular Diseases

Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—A nation wide database analysis

(2011) Lian-Yu Lin et al.   ATHEROSCLEROSIS

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

(2011) John A. Cairns et al.   CANADIAN JOURNAL OF CARDIOLOGY

Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation

(2011) Jonas Bjerring Olesen et al.   CHEST

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

(2011) Shimoli V. Shah et al.   CIRCULATION

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation

(2011) Rangadham Nagarakanti et al.   CIRCULATION

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

(2011) L. Samuel Wann et al.   CIRCULATION

Safety of Percutaneous Left Atrial Appendage Closure

(2011) Vivek Y. Reddy et al.   CIRCULATION

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST)

(2011) Lucas V.A. Boersma et al.   CIRCULATION

Radiofrequency Catheter Ablation and Antiarrhythmic Drug Therapy

(2011) Carlo Pappone et al.   Circulation-Arrhythmia and Electrophysiology

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial

(2011) Andreas Goette et al.   Circulation-Arrhythmia and Electrophysiology

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

(2011) P. Kirchhof et al.   EUROPACE

Rationale and current perspective for early rhythm control therapy in atrial fibrillation

(2011) I. C. Van Gelder et al.   EUROPACE

Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment

(2011) A. Hakalahti et al.   EUROPACE

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

(2011) I. Savelieva et al.   EUROPACE

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

(2011) I. Savelieva et al.   EUROPACE

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation

(2011) N. Freemantle et al.   EUROPACE

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

(2011) G. Y. H. Lip et al.   EUROPACE

Catheter ablation of atrial fibrillation as first-line therapy--a single-centre experience

(2011) H. Tanner et al.   EUROPACE

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

(2011) K. A. A. Fox et al.   EUROPEAN HEART JOURNAL

Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors

(2011) Hana Hoyt et al.   HEART RHYTHM

Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin

(2011) Rakesh Latchamsetty et al.   HEART RHYTHM

The Use of Dabigatran Immediately After Atrial Fibrillation Ablation

(2011) ROGER A. WINKLE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Incidence of Silent Cerebral Thromboembolic Lesions After Atrial Fibrillation Ablation May Change According to Technology Used: Comparison of Irrigated Radiofrequency, Multipolar Nonirrigated Catheter and Cryoballoon

(2011) FIORENZO GAITA et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation

(2011) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incidence of Asymptomatic Intracranial Embolic Events After Pulmonary Vein Isolation

(2011) Claudia Herrera Siklódy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation

(2011) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Catheter Ablation for Atrial Fibrillation

(2011) Rukshen Weerasooriya et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation

(2011) A. John Camm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stroke in atrial fibrillation: epidemiology and thromboprophylaxis

(2011) G. Y. H. LIP   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

(2011) J. B. OLESEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Atrial fibrillation

(2011) Gregory YH Lip et al.   LANCET

The role of aspirin for stroke prevention in atrial fibrillation

(2011) Gregory Y. H. Lip   Nature Reviews Cardiology

Catheter Ablation for Atrial Fibrillation

(2011) Oussama Wazni et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dronedarone in High-Risk Permanent Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

(2011) John H. Alexander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

(2011) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring

(2011) Giuseppe Boriani et al.   STROKE

Left Atrial Catheter Ablation and Ischemic Stroke

(2011) Karl Georg Haeusler et al.   STROKE

Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients

(2011) Isla M. Ogilvie et al.   THROMBOSIS AND HAEMOSTASIS

Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions

(2011) Andrea Gerth et al.   THROMBOSIS AND HAEMOSTASIS

Measuring the anticoagulant effect of direct factor Xa inhibitors. Is the anti-Xa assay preferable to the prothrombin time test?

(2011) Armando Tripodi   THROMBOSIS AND HAEMOSTASIS

Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

(2011) K. Airaksinen et al.   THROMBOSIS AND HAEMOSTASIS

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective

(2011) Anuraag Kansal et al.   THROMBOSIS AND HAEMOSTASIS

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients

(2011) Arlene Gallagher et al.   THROMBOSIS AND HAEMOSTASIS

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke

(2011) Emma Wallace et al.   THROMBOSIS AND HAEMOSTASIS

Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.

(2011) Luciano Crippa et al.   THROMBOSIS AND HAEMOSTASIS

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study

(2011) Amitava Banerjee et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

(2010) Christian T. Ruff et al.   AMERICAN HEART JOURNAL

A multicenter, open-label study of vernakalant for the conversion of atrial fibrillation to sinus rhythm

(2010) Ian G. Stiell et al.   AMERICAN HEART JOURNAL

Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation

(2010) Craig M. Pratt et al.   AMERICAN JOURNAL OF CARDIOLOGY

Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?

(2010) Gregory Y.H. Lip et al.   AMERICAN JOURNAL OF MEDICINE

Left atrial appendage closure with amplatzer cardiac plug in atrial fibrillation: Initial european experience

(2010) Jai-Wun Park et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation

(2010) Feifan Ouyang et al.   CIRCULATION

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2010) Luigi Di Biase et al.   CIRCULATION

Excessive Supraventricular Ectopic Activity and Increased Risk of Atrial Fibrillation and Stroke

(2010) Zeynep Binici et al.   CIRCULATION

Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation

(2010) Michael D. Ezekowitz et al.   CIRCULATION

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

(2010) et al.   CIRCULATION

Long-Term Outcome After Successful Catheter Ablation of Atrial Fibrillation

(2010) Wendy S. Tzou et al.   Circulation-Arrhythmia and Electrophysiology

Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)

(2010) Peter Leong-Sit et al.   Circulation-Arrhythmia and Electrophysiology

Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II Study)

(2010) T. Yamashita et al.   EUROPACE

n-3 Polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study

(2010) L. Bianconi et al.   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W

(2010) Raffaele De Caterina et al.   EUROPEAN HEART JOURNAL

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

(2010) G. Y. H. Lip et al.   EUROPEAN HEART JOURNAL

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

(2010) David J. Wilber et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation

(2010) Peter R. Kowey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Catheter Ablation for Atrial Fibrillation on Uninterrupted Warfarin: Can It Be Done Without Echo Guidance?

(2010) STEPHEN P. PAGE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Effect of Therapeutic INR on Activated Clotting Times, Heparin Dosage, and Bleeding Risk During Ablation of Atrial Fibrillation

(2010) SANDEEP GAUTAM et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

A Short-Term, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study

(2010) JEAN-YVES LE HEUZEY et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Dronedarone Therapy in Atrial Fibrillation: A Summary of Recent Controlled Trials

(2010) Gabor Z. Duray et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

(2010) T. P. VAN STAA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Newly Identified Events in the RE-LY Trial

(2010) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay

(2010) Zhaoqing Wang et al.   THROMBOSIS AND HAEMOSTASIS

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

(2010) John W. Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study

(2010) Yves-Laurent Bayard et al.   EuroIntervention

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin

(2009) Richard P. Whitlock et al.   CIRCULATION

Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery

(2009) Peter R. Kowey et al.   Circulation-Arrhythmia and Electrophysiology

Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation

(2009) Hugh Calkins et al.   Circulation-Arrhythmia and Electrophysiology

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

(2009) Riccardo Cappato et al.   Circulation-Arrhythmia and Electrophysiology

Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'

(2009) P. Kirchhof et al.   EUROPACE

Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients

(2009) A. Arya et al.   EUROPACE

Comparative Efficacy of Dronedarone and Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

(2009) Jonathan P. Piccini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

(2009) Stefan H. Hohnloser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Atrial Fibrillation Ablation in Patients with Therapeutic International Normalized Ratios

(2009) MARTIN SCHMIDT et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?

(2009) Alan G. Dawson et al.   Interactive Cardiovascular and Thoracic Surgery

Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study

(2008) Jean-Marc Davy et al.   AMERICAN HEART JOURNAL

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

(2008) Denis Roy et al.   CIRCULATION

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

(2008) Stuart J. Connolly et al.   CIRCULATION

Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation

(2008) Sheba Ahmed et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early Recurrences After Atrial Fibrillation Ablation: Prognostic Value and Effect of Early Reablation

(2008) NICOLAS LELLOUCHE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Increased Mortality after Dronedarone Therapy for Severe Heart Failure

(2008) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

(2008) Christopher Ll. Morgan et al.   THROMBOSIS RESEARCH